{"owner": "ArrayExpress Uploader", "ownerprofile_id": "arrayexpress_sid", "species": "human", "factors": [{"GSM897018": {"CELL LINE": "epithelioid sarcoma VA-ES-BJ cells", "COMPOUND": "Trail"}}, {"GSM897017": {"CELL LINE": "epithelioid sarcoma VA-ES-BJ cells", "COMPOUND": "Taurolidine"}}, {"GSM897016": {"CELL LINE": "epithelioid sarcoma VA-ES-BJ cells", "COMPOUND": "Trail and Taurolidine"}}, {"GSM897015": {"CELL LINE": "epithelioid sarcoma VA-ES-BJ cells", "COMPOUND": "untreated"}}, {"GSM897014": {"CELL LINE": "leiomyosarcoma SK-LMS-1 cells", "COMPOUND": "Trail"}}, {"GSM897013": {"CELL LINE": "leiomyosarcoma SK-LMS-1 cells", "COMPOUND": "Taurolidine"}}, {"GSM897012": {"CELL LINE": "leiomyosarcoma SK-LMS-1 cells", "COMPOUND": "Trail and Taurolidine"}}, {"GSM8970": {"CELL LINE": "leiomyosarcoma SK-LMS-1 cells", "COMPOUND": "untreated"}}, {"GSM897010": {"CELL LINE": "rhabdomyosacrcoma A-204 cells", "COMPOUND": "Trail"}}, {"GSM897009": {"CELL LINE": "rhabdomyosacrcoma A-204 cells", "COMPOUND": "Taurolidine"}}, {"GSM897008": {"CELL LINE": "rhabdomyosacrcoma A-204 cells", "COMPOUND": "Trail and Taurolidine"}}, {"GSM897007": {"CELL LINE": "rhabdomyosacrcoma A-204 cells", "COMPOUND": "untreated"}}], "id": 2505, "pop_total": 0, "platform": 4, "summary_wrapped": "Microarray analysis revealed differential gene expression patterns of rhabdomyosarcoma (A-204), leiomyosarcoma (SK-LMS-1) and epithelioid...", "geo_gse_id": "E-GEOD-36572", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 2, "sample_count": 12, "tags": ["carcinoma", "cell", "epithelioid cell", "epithelioid cell sarcoma", "leiomyosarcoma", "rhabdomyosarcoma", "sarcoma"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_gds_id": "", "slug": "synergistic-effects-of-trail-and-taurolidine-on-so", "geo_id_plat": "E-GEOD-36572_A-AFFY-44", "name": "Synergistic effects of TRAIL and taurolidine on soft tissue sarcoma cell lines", "created": "Jul.12, 2014", "summary": "Microarray analysis revealed differential gene expression patterns of rhabdomyosarcoma (A-204), leiomyosarcoma (SK-LMS-1) and epithelioid cell sarcoma (VA-ES-BJ) cells treated with TRAIL and/or taurolidine. To explore new therapeutic options in the treatment of sarcomas, we tested the antibiotic taurolidine (TRD) on A-204, SK-LMS-1 and VA-ES-BJ carcinoma cell lines alone and in combination with rhTRAIL (TNF related apoptosis-inducing ligand). Gene expression was analysed by RNA microarray. Cell lines were treated with Taurolidine, Trail and a combination of both and compaired to untreated cells", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-36572", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-36572/samples/"}